Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for ImmunoTech (AIM) over the last 9 years, with Q3 2025 value amounting to $296000.0.

  • ImmunoTech's Change in Acquisitions & Divestments fell 3983.74% to $296000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 7036.65%. This contributed to the annual value of $10.1 million for FY2022, which is 5476.85% down from last year.
  • As of Q3 2025, ImmunoTech's Change in Acquisitions & Divestments stood at $296000.0, which was down 3983.74% from $981000.0 recorded in Q2 2025.
  • In the past 5 years, ImmunoTech's Change in Acquisitions & Divestments ranged from a high of $1.1 million in Q2 2024 and a low of $50000.0 during Q1 2024